antipsychotic drugs. Clinical manifestations of NMS are hyperpyrexia pregnancy outcomes in women exposed to atypical antipsychotics, including
Use In Pregnancy Lactation. Pregnancy: Pregnancy Category C. Risk Summary: Neonates exposed to antipsychotic drugs (including Aripiprazole (Abilify))
Pregnancy: Neonates exposed to antipsychotic drugs, including ABILIFY pregnancy outcomes in women exposed to ABILIFY MYCITE during pregnancy.
Pregnancy: Neonates exposed to antipsychotic drugs, including ABILIFY MYCITE, during the third trimester of pregnancy are at risk for extrapyramidal and/or
antipsychotic drugs. Clinical manifestations of NMS are hyperpyrexia pregnancy outcomes in women exposed to atypical antipsychotics, including
Pregnancy: Neonates exposed to antipsychotic drugs, including aripiprazole, during the third trimester of pregnancy are at risk for extrapyramidal and/or
Pregnancy: Neonates exposed to antipsychotic drugs, including aripiprazole, during the third trimester of pregnancy are at risk for extrapyramidal and/or
Atypical Antipsychotics. Andrade C. 2024. Major congenital malformations associated with exposure to second-generation antipsychotic drugs during pregnancy.
Drug class: Atypical antipsychotics. Medically reviewed by Philip Taking antipsychotic medicine in the last 3 months of pregnancy may cause
Comments